{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:50:08Z","timestamp":1793155808117,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T00:00:00Z","timestamp":1700265600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jdiacomp.2022.108357","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T02:24:55Z","timestamp":1668392695000},"page":"108357","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Present and future directions in diabetic kidney disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Christine P.","family":"Limonte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kretzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subramaniam","family":"Pennathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodica","family":"Pop-Busui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2022.108357_bb0005","series-title":"IDF diabetes atlas","volume":"102","year":"2021"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archinternmed.2011.16","article-title":"Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria","volume":"171","author":"de Boer","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0015","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.2215\/CJN.03700417","article-title":"Diabetes and CKD in the United States population, 2009\u20132014","volume":"12","author":"Zelnick","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0020","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/ajt.16657","article-title":"Reported cases of end-stage kidney disease\u2014United States, 2000\u20132019","volume":"22","author":"R\u00edos Burrows","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0025","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1001\/jama.2016.10924","article-title":"Clinical manifestations of kidney disease among US adults with diabetes, 1988\u20132014","volume":"316","author":"Afkarian","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1681\/ASN.2018050531","article-title":"Projecting ESRD incidence and prevalence in the United States through 2030","volume":"30","author":"McCullough","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0035","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0040","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0045","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2337\/db08-1543","article-title":"The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes","volume":"58","author":"Groop","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0050","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1007\/s00125-010-1860-3","article-title":"In the absence of renal disease, 20 year mortality risk in type 1 diabetes is comparable to that of the general population: a report from the Pittsburgh epidemiology of diabetes complications study","volume":"53","author":"Orchard","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0055","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease","volume":"108","author":"Sarnak","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/j.ackd.2014.03.003","article-title":"Cardiovascular complications of diabetic kidney disease","volume":"21","author":"P\u00e1lsson","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0065","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report website. Accessed July 12, 2022. https:\/\/www.cdc.gov\/diabetes\/data\/statistics-report\/index.html."},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1053\/j.ackd.2014.07.002","article-title":"Socioeconomic disparities in chronic kidney disease","volume":"22","author":"Nicholas","year":"2015","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0075","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0080","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes: U.K. prospective diabetes study 74","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0085","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2337\/dc15-2322","article-title":"Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON","volume":"39","author":"Wong","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0090","article-title":"Standards of medical care in diabetes-2009","volume":"32","author":"Classification","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0095","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0100","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1001\/archinte.163.13.1555","article-title":"Effects of blood pressure level on progression of diabetic nephropathy: results from the RENAAL study","volume":"163","author":"Bakris","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0105","article-title":"Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease","volume":"4","author":"Strippoli","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes (RASS)","volume":"361","author":"Mauer","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eclinm.2021.101163","article-title":"Net effects of sodium-glucose co-transporter-2 inhibition in different patient groups: a meta-analysis of large placebo-controlled randomized trials","volume":"41","author":"Staplin","year":"2021","journal-title":"eClinicalMedicine."},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0120","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(19)30256-6","article-title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"7","author":"Neuen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0125","first-page":"1","article-title":"GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs","volume":"20","author":"Giugliano","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0130","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s40265-021-01554-6","article-title":"Evolution of type 2 diabetes management from a glucocentric approach to cardio-renal risk reduction: the new paradigm of care","volume":"81","author":"Jacob","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0135","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.2337\/dc22-Srev","article-title":"Summary of revisions: standards of medical care in diabetes\u20142022","volume":"45","author":"Care","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0140","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. in Press."},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0145","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0150","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1016\/S0140-6736(19)30772-X","article-title":"Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial","volume":"393","author":"Heerspink","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0155","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0160","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.kint.2020.08.039","article-title":"Rationale and design of the kidney precision medicine project","volume":"99","author":"de Boer","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0165","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.kint.2019.07.025","article-title":"Integrative analysis of prognostic biomarkers derived from multiomics panels helps discrimination of chronic kidney disease trajectories in people with type 2 diabetes","volume":"96","author":"Kammer","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.kint.2019.09.020","article-title":"Rationale and design of the transformative research in diabetic nephropathy (TRIDENT) study","volume":"97","author":"Townsend","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physiolgenomics.00104.2020","article-title":"A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the kidney precision medicine project","volume":"53","author":"El-Achkar","year":"2021","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/jci.insight.133267","article-title":"Single cell transcriptomics identifies focal segmental glomerulosclerosis remission endothelial biomarker","volume":"5","author":"Menon","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0185","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2020.00499","article-title":"Near-single-cell proteomics profiling of the proximal tubular and glomerulus of the normal human kidney","volume":"7","author":"Sigdel","year":"2020","journal-title":"Front Med"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0190","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ekir.2020.11.032","article-title":"Establishing a case for anti-complement therapy in membranous nephropathy","volume":"6","author":"Ayoub","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0195","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41581-020-0321-6","article-title":"Digital pathology and computational image analysis in nephropathology","volume":"16","author":"Barisoni","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0200","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41581-020-0286-5","article-title":"Integrated multi-omics approaches to improve classification of chronic kidney disease","volume":"16","author":"Eddy","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0205","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2215\/CJN.10270620","article-title":"Integrating patient priorities with science by community engagement in the kidney precision medicine project","volume":"16","author":"Tuttle","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0210","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.ajkd.2021.10.004","article-title":"Quantification of glomerular structural lesions: associations with clinical outcomes and transcriptomic profiles in nephrotic syndrome","volume":"79","author":"Hodgin","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0215","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1053\/j.ajkd.2018.07.020","article-title":"CureGN study rationale, design, and methods: establishing a large prospective observational study of glomerular disease","volume":"73","author":"Mariani","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1681\/ASN.2017030350","article-title":"Impaired B-oxidation and altered complex lipid fatty acid partitioning with advancing CKD","volume":"29","author":"Afshinnia","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0225","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2337\/db14-0509","article-title":"Metabolomics and diabetes: analytical and computational approaches","volume":"64","author":"Sas","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0230","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1056\/NEJMra1104901","article-title":"The human plasma lipidome","volume":"365","author":"Quehenberger","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0235","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11886-021-01455-w","article-title":"Mechanisms and treatment of dyslipidemia in diabetes","volume":"23","author":"Bahiru","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0240","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41581-021-00488-2","article-title":"Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease","volume":"18","author":"Baek","year":"2022","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0245","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.2337\/dc16-1246","article-title":"Plasma triglycerides and HDL-C levels predict the development of diabetic kidney disease in subjects with type 2 diabetes: the AMD annals initiative","volume":"39","author":"Russo","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0250","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/nrneph.2018.9","article-title":"Mitochondrial dysfunction in diabetic kidney disease","volume":"14","author":"Forbes","year":"2018","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0255","article-title":"Tissue-specific metabolic reprogramming drives nutrient flux in diabetic complications","volume":"1","author":"Sas","year":"2016","journal-title":"JCIInsight"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0260","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1681\/ASN.2013020126","article-title":"Metabolomics reveals signature of mitochondrial dysfunction in diabetic kidney disease","volume":"24","author":"Sharma","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0265","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1194\/jlr.P040501","article-title":"Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy","volume":"55","author":"Herman-Edelstein","year":"2014","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0270","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.cbi.2014.06.029","article-title":"Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications","volume":"220","author":"Zhao","year":"2014","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0275","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn4965","article-title":"A reference tissue atlas for the human kidney","volume":"8","author":"Hansen","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0280","article-title":"Increased lipogenesis and impaired B-oxidation predict type 2 diabetic kidney disease progression in American Indians","volume":"4","author":"Afshinnia","year":"2019","journal-title":"JCIInsight"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0285","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1908706116","article-title":"The single cell transcriptomic landscape of early human diabetic nephropathy","author":"Wilson","year":"2019","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0290","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1681\/ASN.2018090896","article-title":"Single-cell RNA profiling of glomerular cells shows dynamic changes in experimental diabetic kidney disease","volume":"30","author":"Fu","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0295","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/sciadv.abd3359","article-title":"Molecular characterization of the human kidney interstitium in health and disease","volume":"7","author":"Barwinska","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0300","article-title":"Molecular signatures of diabetic kidney disease hiding in a patient with hypertension-related kidney disease","author":"Patel","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0305","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.kint.2017.08.013","article-title":"A molecular morphometric approach to diabetic kidney disease can link structure to function and outcome","volume":"93","author":"Nair","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0310","series-title":"An Atlas of Healthy and Injured Cell States and Niches in the Human Kidney","author":"Lake","year":"2021"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0315","doi-asserted-by":"crossref","DOI":"10.2337\/dc21-0737","article-title":"Circulating free fatty acid and phospholipid signature predicts early rapid kidney function decline in patients with type 1 diabetes","author":"Afshinnia","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0320","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1093\/bioinformatics\/btz114","article-title":"Differential network enrichment analysis reveals novel lipid pathways in chronic kidney disease","volume":"35","author":"Ma","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmet.2022.05.010","article-title":"Mapping the single-cell transcriptomic response of murine diabetic kidney disease to therapies","volume":"34","author":"Wu","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0330","article-title":"Renin-angiotensin system inhibition reverses the altered triacylglycerol metabolic network in diabetic kidney disease","volume":"17","author":"Sas","year":"2022","journal-title":"Metabolomics"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0335","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/14728222.2019.1624721","article-title":"Diabetic nephropathy: an insight into molecular mechanisms and emerging therapies","volume":"23","author":"Warren","year":"2019","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/biom12091227","article-title":"Oxidative stress and NRF2\/KEAP1\/ARE pathway in diabetic kidney disease (DKD): new perspectives","volume":"12","author":"Tanase","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/antiox11071356","article-title":"Tubular mitochondrial dysfunction, oxidative stress, and progression of chronic kidney disease","volume":"11","author":"Fontecha-Barriuso","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0350","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1053\/j.ajkd.2011.06.020","article-title":"Sulodexide for kidney protection in type 2 diabetes patients with microalbuminuria: a randomized controlled trial","volume":"58","author":"Lewis","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0355","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4989847","article-title":"Sulodexide protects renal tubular epithelial cells from oxidative stress-induced injury via upregulating klotho expression at an early stage of diabetic kidney disease","author":"Liu","year":"2017","journal-title":"J Diabetes Res"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0360","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2337\/db15-0384","article-title":"ASK1 inhibitor halts progression of diabetic nephropathy in Nos3-deficient mice","volume":"64","author":"Tesch","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0365","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/ndt\/gfx377","article-title":"JAK1\/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a phase 2 randomized controlled clinical trial","volume":"33","author":"Tuttle","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/s41581-020-00335-w","article-title":"Modelling kidney disease using ontology: insights from the kidney precision medicine project","volume":"16","author":"Ong","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0375","series-title":"CEUR Workshop Proc","first-page":"1","article-title":"KTAO: A kidney tissue atlas ontology to support community-based kidney knowledge base development and data integration","volume":"2285","author":"He","year":"2018"},{"key":"10.1016\/j.jdiacomp.2022.108357_bb0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-48263-5","article-title":"Artificial intelligence predicts the progression of diabetic kidney disease using big data machine learning","volume":"9","author":"Makino","year":"2019","journal-title":"Sci Rep"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722002690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872722002690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:16:25Z","timestamp":1761005785000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872722002690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":76,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S1056872722002690"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108357","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Present and future directions in diabetic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108357"}}